A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study of the Safety of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months With Symptoms of Allergic Rhinitis or Chronic Urticaria

Trial Profile

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study of the Safety of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months With Symptoms of Allergic Rhinitis or Chronic Urticaria

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Mar 2015

At a glance

  • Drugs Levocetirizine (Primary)
  • Indications Allergic rhinitis
  • Focus Adverse reactions
  • Acronyms BALL
  • Sponsors UCB
  • Most Recent Events

    • 16 Oct 2008 Actual patient number (69) added as reported by CT.gov
    • 16 Oct 2008 Status changed active, not recruiting to completed as reported by CT.gov
    • 07 Oct 2008 Status changed from recruiting to active, not recruiting as reported by CT.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top